tirzepatide pancreas Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m What is the effect of

The most common side effects are gastrointestinal, including nausea (2040% of patients), diarrhoea, vomiting, constipation, and abdominal discomfort

The standard titration schedule increases the dose every four weeks, and patients may experience transient symptoms as their body adjusts to higher medication levels

While TBI induction decreased the expression (0 fold) in rats in Group II

Expect long-term treatment

This continues building with each weekly injection

No cases of pancreatitis or thyroid malignancy were reported during the trial period, though these remain areas of ongoing surveillance given their association with this drug class